Skip to main content
Fig. 4 | Cancer Imaging

Fig. 4

From: Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitors

Fig. 4

Change of tumor size from baseline to pseudoprogression. NSCLC Non-small cell lung cancer, RCC renal cell carcinoma, HCC hepatocellular carcinoma, ENT ear nose throat tumor, CUP carcinoma of unknown primary, CRC colorectal carcinoma, CCC cholangiocellular carcinoma, PDAC pancreatic ductal adenocarcinoma, SLCL small cell lung cancer, UCC urothelium cell carcinoma. NTL non-target lesion

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us